Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HIF1A | Q16665 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | PDE4A | P27815 | 1/20 | 0.42 |
| ▸ | KDR | P35968 | 1/20 | 0.42 |
| ▸ | CXCR4 | P61073 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1640 | 1.00 | — | — | |
| Water SCHEMBL10563748 | 0.96 | — | — | |
| SCHEMBL567629 | 0.96 | — | — | |
| SCHEMBL1782381 | 0.96 | HIF1A (0.50) | HIF1AMAPTPDE4AKDRCXCR4 | |
| SCHEMBL1781454 | 0.96 | HIF1A (0.50) | HIF1AMAPTPDE4AKDRCXCR4 | |
| Hydrochloric Acid SCHEMBL3631500 | 0.96 | — | — | |
| SCHEMBL1781357 | 0.96 | HIF1A (0.50) | HIF1AMAPTPDE4AKDRCXCR4 | |
| Hydrochloric Acid SCHEMBL10488917 | 0.96 | — | — | |
| SCHEMBL1782806 | 0.96 | — | — | |
| SCHEMBL1864743 | 0.92 | HIF1A (0.46) | HIF1AMAPTPDE4AKDRCXCR4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 122 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11332416-B2 | Process for synthesizing fluorinated cyclic aliphatic compounds | Westfälische Wilhelms-Universität Münster (DE) | 2022-05-17 | — | — | US | disclosed |
| EP-3601203-B1 | PROCESS FOR SYNTHESIZING FLUORINATED CYCLIC ALIPHATIC COMPOUNDS | UNIV MUENSTER WESTFAELISCHE WILHELMS (DE) | 2021-04-07 | — | — | EP | disclosed |
| WO-2020200681-A1 | POLYMERIZATION METHOD | RHEINISCH-WESTFÄLISCHE TECHNISCHE HOCHSCHULE (RWTH) AACHEN (DE) | 2020-10-08 | — | — | WO | disclosed |
| US-10581001-B2 | Organic electronic component having a charge carrier generation layer and the use of a zinc complex as a P-type dopant in charge carrier generation layers | OSRAM OLED GMBH (DE) | 2020-03-03 | — | — | US | disclosed |
| EP-3601203-A1 | PROCESS FOR SYNTHESIZING FLUORINATED CYCLIC ALIPHATIC COMPOUNDS | Westfälische Wilhelms-Universität Münster (DE) | 2020-02-05 | — | — | EP | disclosed |
| US-10411197-B2 | Main group metal complexes as P-dopants for organic electronic matrix materials | SIEMENS AKTIENGESELLSCHAFT (DE) | 2019-09-10 | — | — | US | disclosed |
| WO-2019162391-A1 | METHOD FOR PRODUCING FLUORINATED HETEROCYCLIC ALIPHATIC COMPOUNDS | Westfälische Wilhelms-Universität Münster (DE) | 2019-08-29 | — | — | WO | disclosed |
| CN-104662687-B | Salts of phosphorus oxide for use as n-type dopants in organic electronic devices | 西门子公司 | 2019-06-14 | — | — | CN | disclosed |
| US-10305047-B2 | Main group metal complexes as p-dopants for organic electronic matrix materials | SIEMENS AKTIENGESELLSCHAFT (DE) | 2019-05-28 | — | — | US | disclosed |
| US-10256422-B2 | Organic electronic component, use of a zinc complex as a p-dopant for organic electronic matrix materials | OSRAM OLED GMBH (DE) | 2019-04-09 | — | — | US | disclosed |
| WO-2001064994-A1 | METHOD FOR REDUCING DYE FADING OF FABRICS IN LAUNDRY BLEACHING COMPOSITIONS | UNILEVER PLC (GB) | 2001-09-07 | — | — | WO | disclosed |
| US-20010009271-A1 | Bleaching composition | UNILEVER HOME & PERSONAL CARE USA, DIVISION OF CONOPCO, INC. | 2001-07-26 | — | — | US | disclosed |
| WO-2001048138-A2 | BLEACHING COMPOSITION | UNILEVER N.V. (NL) | 2001-07-05 | — | — | WO | disclosed |
| WO-2001048137-A1 | BLEACHING COMPOSITION | UNILEVER N.V. (NL) | 2001-07-05 | — | — | WO | disclosed |
| WO-2001016261-A2 | COMPOSITION AND METHOD FOR BLEACHING A SUBSTRATE | UNILEVER PLC (GB) | 2001-03-08 | — | — | WO | disclosed |
| WO-2001016268-A1 | METHOD OF PRETREATING AND BLEACHING STAINED FABRICS | UNILEVER PLC (GB) | 2001-03-08 | — | — | WO | disclosed |
| WO-2001016270-A1 | COMPOSITION AND METHOD FOR BLEACHING A SUBSTRATE | UNILEVER PLC (GB) | 2001-03-08 | — | — | WO | disclosed |
| WO-2001016272-A2 | LIGAND AND COMPLEX FOR CATALYTICALLY BLEACHING A SUBSTRATE | UNILEVER PLC (GB) | 2001-03-08 | — | — | WO | disclosed |
| WO-2000060044-A1 | COMPOSITION AND METHOD FOR BLEACHING A SUBSTRATE | UNILEVER PLC (GB) | 2000-10-12 | — | — | WO | disclosed |
| WO-2000060043-A1 | COMPOSITION AND METHOD FOR BLEACHING A SUBSTRATE | UNILEVER PLC (GB) | 2000-10-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11332416-B2 | Process for synthesizing fluorinated cyclic aliphatic compounds | HRH4, HRH1, AHR | HIF1A 3395/4885MAPT 3794/4885PDE4A 3569/4885 |
| US-10581001-B2 | Organic electronic component having a charge carrier generation layer and the use of a zinc complex as a P-type dopant in charge carrier generation layers | SCO2, NCOA4, NR4A2 | HIF1A 3899/4885MAPT 4425/4885PDE4A 4488/4885 |
| US-10305047-B2 | Main group metal complexes as p-dopants for organic electronic matrix materials | SCO2, SOD3, NCOA3 | HIF1A 4395/4885MAPT 3340/4885PDE4A 4821/4885 |
| US-10411197-B2 | Main group metal complexes as P-dopants for organic electronic matrix materials | SCO2, KMO, NOXO1 | HIF1A 3920/4885MAPT 4018/4885PDE4A 4739/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.